Sichuan Dawn Precision Technology Co.Ltd(300780) : final financial statement report of 2021

Sichuan Dawn Precision Technology Co.Ltd(300780)

Financial settlement plan for 2021

The company’s 2021 financial statements have been audited by Lixin Certified Public Accountants (special general partnership) and issued a standard unqualified audit report. The audit opinion of the accountant is: we have audited the financial statements of Sichuan Dawn Precision Technology Co.Ltd(300780) (hereinafter referred to as ” Sichuan Dawn Precision Technology Co.Ltd(300780) company”), including the consolidated and parent company’s balance sheet as of December 31, 2021, the consolidated and parent company’s income statement, consolidated and parent company’s cash flow statement, consolidated and parent company’s statement of changes in owner’s equity and notes to relevant financial statements in 2021. The financial statements of the parent company as of December 31, 2020 and the consolidated financial statements of the parent company reflect the significant financial results of the parent company as of December 31, 2020.

1、 Analysis of financial status, operating results and cash flow (unit: yuan)

(I) changes in main indicators of assets:

Indicator Name: change range of balance this year and main reasons for change

Monetary capital 10669937828 14.27%, including deposit of RMB 40 million such as bills of exchange

The average account receivable period is less than 11 Huatai Securities Co.Ltd(601688) 6 months, and the average account receivable period is less than 11601257 months

Other receivables 1129490132 – 72.46% recovered from the government’s repurchase of Yanguan Road plant

Inventory 44856634677 113.24% purchased land of about 160 million

Fixed assets 55249602107 73.18% of Pingshan raised investment project transferred to fixed assets

37206353240% of construction in progress and 18.56% of the investment of raised investment projects

Intangible assets 7181576163 1.93% no significant change

(II) changes in main indicators of liabilities:

Indicator Name: change range of balance this year and main reasons for change

28316623709 358.31% of the short-term borrowings were returned to the temporary supplementary current capital of 63.61 million yuan, and then the working capital was supplemented

Accounts payable 10402258779 41.12% increase in equipment payables

7127080243 371.37% of the notes payable are pledged to the bank with the received bank acceptance

Due to exchange of bills of exchange

Other payables 429784676, 54.44% of the deposit payable, sea freight, etc

Long term loan 8950000000 79.00% to supplement working capital

(III) changes in main indicators of shareholders’ equity:

Indicator Name: change range of balance this year and main reasons for change

Share capital 14667000000-

Undistributed profit 32644109114 16.19% profit and dividend distribution of this year

(IV) changes in main profit indicators:

Index name: change range from 2021 to 2020

Total operating revenue 5801026156245132503889 28.53%

Operating cost 4096951776532782232684 24.97%

Taxes and surcharges 660936645654369129 1.00%

Sales expense 29998566332551877797 17.55%

Administrative expenses 35768527243318098937 7.80%

Financial expenses 1268495700601391629 110.93%

Including: interest expense 8898130992 Xiangyumedicalco.Ltd(688626) 80 230.95%

Exchange gain / loss 369328037464453925 – 20.48%

Net profit 70949897279807862266 – 27.66%

Net profit after non deduction: 61483801923292449834 86.74%

Note: the 110.93% increase in financial expenses was mainly due to the increase in financing; The net profit decreased by 27.66%, mainly because the net profit in 2020 included about 50 million yuan of government repurchase, and the net profit of the company increased by 86.74% after deducting non recurring income this year

(V) main indicators of cash flow:

Index name 2021 remarks

The net cash flow from operating activities was -12684177366, mainly due to the purchase of land of about 160 million

Net cash flow from investing activities – 22041926515 investment in raised investment projects

The net cash flow from financing activities is 32571854754, which is mainly financed by banking institutions

2、 Main financial indicators

Project index name formula 20212020

Gross profit margin (sales revenue – cost of sales) / sales revenue 100% 29.38 27.36

Capacity return on net assets net profit / average net assets 100% 6.57 9.70

Target sales profit margin total profit / net sales revenue 100% 14.53 25.29

Current ratio current assets / current liabilities 1.25 2.57

Debt service (current assets – inventories – prepayments – deferred expenses) / current

Capacity quick ratio current liabilities 0.48 1.56

index

Asset liability ratio total liabilities / total assets 100% 42.02 25.36

Turnover rate of accounts receivable net sales (operating) income / average balance of accounts receivable 5.83 5.94

assets

Operation accounts receivable turnover days 360 / accounts receivable turnover rate 61.79 60.63

Capacity total asset turnover rate net sales (operating) income / average total assets 100% 34.82 35.05

index

Fund recovery rate annual collection / income 87.81 96.51

The above data are detailed in the audit report of the company – 2021.

Sichuan Dawn Precision Technology Co.Ltd(300780) board of directors

April 25, 2022

- Advertisment -